Andrew (Andy) focuses on corporate and transactional matters for a wide variety of clients covering the entire business life cycle, from start-up (formation and organization) to seed and venture stage funding to growth stage (later stage funding, corporate collaborations and buy-side M&A) and ultimately exit (sell-side M&A or IPO). Andy actively works with his clients in all such phases and often serves as outside general counsel to his clients, handling and/or overseeing day-to-day matters including corporate governance, labor and employment, customer agreements, strategic partnerships, tax, IP, privacy and cybersecurity, cross-border transactions, real estate leasing and dispute resolution.

On the institutional side, Andy represents VC funds, angel investors, family offices and private foundations in investing in and/or collaborating with their portfolio companies and also has represented investment banks in public offerings, private placements and M&A transactions.

Andy works primarily with life sciences companies (biotech, pharma, digital health and health care) and high-tech companies but also represents clients in such industries as consulting, real estate, professional services and food services.